• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Belgium·Consumer Cyclical·ALPHS.PA
Share

Pharmasimple S.A. Stocks

€ 0Last Updated 23.03.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

€ 2283.29371

€ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Pharmasimple SA operates a Website for medicines, cosmetics, and food supplements in Belgium and France. It offers beauty and cosmetics products, such as face wash, face care, make-up, hair removal, body care, tanning lotions, and hair treatment products; health products, including feminine hygiene, dental hygiene, alternative medicine, hearing aid, and aromatherapy products; and men care products categories, such as face, body, and hair care, as well as shaving products. The company also provides diet products, sport diet, health supplements, and health food; child care product categories, which include nappies, baby washing, breastfeeding equipment, baby food, and baby care products; and veterinary and pest control products. Pharmasimple SA was founded in 2010 and is based in Houdeng-Goegnies, Belgium.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E. Editor's note: P

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

05.08.2026 09:30

An analyst recommended reducing the proportion of Apple shares in the portfolio due to rising memory prices

05.08.2026 08:30

Weak sales of Wegovy overshadowed Novo's "clearly less-than-impressive" forecast revision

05.08.2026 07:30

Shein is aiming for a valuation of up to $40 billion in its Hong Kong IPO — Reuters

05.08.2026 01:35

SpaceX Exceeded Revenue Expectations: Revenue Nearly Doubled Thanks to Starlink

05.08.2026 01:18

The S&P 500 hit a new record high for the first time since June, driven by earnings reports and hopes that the Strait of Hormuz would reopen

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026